Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
31. lappuse
... milliliter volumetric flask and add 95 percent ethanol to volume and mix . Dilute 10.0 milliliters of this first solution to 100.0 milliliters with 95 per- cent ethanol and mix for the second so- lution . Just prior to use ...
... milliliter volumetric flask and add 95 percent ethanol to volume and mix . Dilute 10.0 milliliters of this first solution to 100.0 milliliters with 95 per- cent ethanol and mix for the second so- lution . Just prior to use ...
303. lappuse
... milliliters of the stock buffer solution ( paragraph ( c ) ( 1 ) ( i ) of this section ) . Dilute with water to approximately 200 milliliters . Adjust the pH to 7.2 using hydrochloric acid or sodium hydroxide . The solution must be ...
... milliliters of the stock buffer solution ( paragraph ( c ) ( 1 ) ( i ) of this section ) . Dilute with water to approximately 200 milliliters . Adjust the pH to 7.2 using hydrochloric acid or sodium hydroxide . The solution must be ...
355. lappuse
... milliliters of polysorbate 80 before sterilization . ( 3 ) Diluting fluid C. To each liter of diluting fluid A add 0.5 gram of sodium thioglycollate , and adjust with NaOH so that after sterilization the final pH will be pH 6.6 ± 0.6 ...
... milliliters of polysorbate 80 before sterilization . ( 3 ) Diluting fluid C. To each liter of diluting fluid A add 0.5 gram of sodium thioglycollate , and adjust with NaOH so that after sterilization the final pH will be pH 6.6 ± 0.6 ...
356. lappuse
... milliliter , use the volume that con- tains 300,000 units , into a sterile 500- milliliter Erlenmeyer flask containing approximately 200 milliliters of dilut- ing fluid A. ( If it is a composite sample packaged in one immediate ...
... milliliter , use the volume that con- tains 300,000 units , into a sterile 500- milliliter Erlenmeyer flask containing approximately 200 milliliters of dilut- ing fluid A. ( If it is a composite sample packaged in one immediate ...
357. lappuse
... milliliter flask containing 100 milliliters of diluting fluid E which has previously been heated to a tem- perature of 47 ° C. Repeat the process , using 10 additional containers . Swirl both of the flasks to dissolve the oint- ment ...
... milliliter flask containing 100 milliliters of diluting fluid E which has previously been heated to a tem- perature of 47 ° C. Repeat the process , using 10 additional containers . Swirl both of the flasks to dissolve the oint- ment ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning